TYMS and non-small cell lung carcinoma: We recently evaluated the abundance of TS in NSCLC tumours of patients treated with carboplatin and paclitaxel, and neither a prognostic nor predictive role was identified for TS expression level in these patients (Takeda et al, 2010).